DA-PBA 2022 offers several opportunities for scientists to present their research work during the symposium through oral communication slots and posters sessions.

Participants wishing to contribute with an oral communication or a poster should submit their abstract respecting the updated calendar below.

The call for abstracts submission is opened and accessible via : https://easychair.org/conferences/?conf=dapba2022

1. Affinity and bioactivity (ligand binding analytics)
2. Biomedical and diagnostic applications (including biomarkers, biosensors, point of care analysis and in vitro diagnostic)
3. Biopharmaceuticals and gene/cell/tissue therapies (ATMPs) (development, bioanalysis, metabolism, etc.)
4. Drug discovery and development (including MS and imaging in ADME studies)
5. Omics for personalized medicine (microbiome, genomics, metabolomics and proteomics, peptidomics, lipidomics, venomics, etc)
6. Micro and nanotools in pharmaceutical analysis (SERS, nanofluidics, nanomagnets, single cell analysis, etc)
7. Natural product pharmaceuticals
8. Pharmaceutical regulatory quality (including novel guidelines, substandard and falsified medicines, vaccines, ATMPs, etc)
9. Pharmaceutical processing (multivariate approaches, fingerprinting, chemometrics, QbD)​
10. Sampling and sample preparation (including non-invasive analytical techniques)​
11. Biophysical and biological quality control techniques for medicines
12. Environmental fate and ecological characteristics of drugs
13. Novel methodologies for drug analysis

The final program is available: DA-PBA2022 Final_Program

	D. Guillarme, Senior lecturer & research associate University of Geneva Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO) Group of Analytical Pharmaceutical Chemistry Switzerland	Protein biopharmaceuticals analysis with advanced chromatography and mass spectrometry approaches
	S. Pedersen-Bjergaard, Professor University of Oslo, Faculty of Mathematics and Natural Sciences, Department of Pharmacy, Section for Pharmaceutical Chemistry Norway	Microextraction using artificial liquid membranes and electrical fields
	G. Kersten Leiden/Amsterdam Center for Drug Research Netherlands	Vaccine characterization: from black box to well-defined biologics
	U. Holzgrabe, Professor Pharmaceutical and Medicinal Chemistry Institute of Pharmacy & Food Chemistry University of Würzburg Germany	Juggling analytes, column chemistry and charged aerosol detection – HPLC analysis of weak chromophore drugs
	H. Wätzig, Professor Institute for Medicinal and Pharmaceutical Chemistry Technische Universität Braunschweig Germany	Biomolecules and their physicochemical properties: charge interactions, CIEF and affinity CE
	Ilona Reischl, Dr. Federal Office for Safety in Health Care Austrian Agency for Health and Food Safety Institute Surveillance Austria	The regulatory perspectives on ATMP development

Keynote

​

	Kelly Zhang Genentech Incorporated USA	Automated high-throughput oligonucleotide-lipid nanoparticle preparation and analytical characterization
	Ann Van Eeckhaut VUB Belgium	Peptide quantification at the picomolar level in volume-limited biological samples: obstacles to tackle
	Janusz Pawliszyn University of Waterloo Canada	Rapid screening by directly coupling sampling/sample preparation devices to mass spectrometry
	Péter Horvatovich University of Groningen Netherlands	Importance of data pre-processing in accurate drug distribution profiling with LC-MS/MS and mass spectrometry imaging
	Luiz Carlos Klein Junior Universidade do Vale do Itajaí Brazil	The use of chemometrics to study natural products
	Rawi Ramautar Leiden University Netherlands	Advances and Utility of Capillary Electrophoresis-Mass Spectrometry in Micro-Metabolomics
	Caroline West Université d’Orléans France	Interest of unified chromatography (UC) to analyze polar biomolecules in pharmaceutical products
	Sibel Özkan Ankara U. Turkey	Electroanalytical Carbon Based Nanosensors: Their potential use in the life sciences and clinical medicine
	Myriam Taverna Université Paris-Saclay France	Miniaturized strategies for Glycosylation analysis of Biopharmaceuticals and disease Biomarkers
	Kenji Hamase Kyushu University Japan	Multi-dimensional HPLC analysis of chiral amino acids in complicated matrices including clinical, food and extraterrestrial samples
	Mario Thevis European Monitoring Center for Emerging Doping Agents Germany	Chromatographic-mass spectrometric approaches in sports drug testing – challen

International Scientific Committee

• A. VAN SCHEPDAEL (KU Leuven, Belgium) | Chair
• C. BARBAS (CEU University, Spain)
• R. BAUER (IPW, Austria)
• C. BERTUCCI (University of Bologna, Italy)
• R. BISCHOFF (University of Groningen, the Netherlands)
• Q. CASS (Federal University of São Carlos, Brazil)
• B. CHANKVETADZE (Tbilisi State University, Georgia)
• J. CROMMEN (University of Liège, Belgium)
• A. DELOBEL (Quality Assistance, Belgium)
• M. FILLET (University of Liege, Belgium)
• P.R. HADDAD (University of Tasmania, Australia)
• J. HAGINAKA (Mukogawa Women’s University, Japan)
• K. HAMASE (Kyushu University, Japan)
• U. HOLZGRABE (University of Wuerzburg, Germany)
• V. IOFFE (Teva, Israel)
• Z. JIANG (Jinan University, China)
• J.-M. KAUFFMANN (Université Libre de Bruxelles, Belgium)
• G. MASSOLINI (University of Pavia, Italy)
• R. MOADDEL (National Institute on Aging, United States)
• V. PICHON (University Paris Sorbonne, P. and M. Curie, Paris, France)
• S. A. ÖZKAN (Ankara University, Turkey)
• S. RUDAZ (University of Geneva, Switzerland)
• K. SANDRA (RIC Group, Belgium)
• G. SOMSEN (Vrije Universiteit Amsterdam, the Netherlands)
• Y. VANDER HEYDEN (Vrije Universiteit Brussel, Belgium)
• J.-L. VEUTHEY (University of Geneva, Switzerland)
• H. WÄTZIG (Institute for Medicinal and Pharmaceutical Chemistry, Germany)
• G. XU (Dalian Institute of Chemical Physics, China)
• K. ZHANG (Genentech, USA)

Local Organizing Committee

• B. BLANKERT (University of Mons)
• C. DELPORTE (Université Libre de Bruxelles)
• A. CECCATO (Mithra Pharmaceuticals)
• A. COVACI (University of Anwerp)
• K. DE BRAEKELEER (Université Libre de Bruxelles)
• B. DE SPIEGELEER (University of Ghent)
• M. FILLET (University of Liège)
• S. HAMBŸE (University of Mons | Exothera)
• G. MUCCIOLI (University of Louvain)
• A. NACHTERGAELE (University of Mons)
• J. SAEVELS (Association of Pharmacists Belgium)
• P. VAN ANTWERPEN (Université Libre de Bruxelles)
• A. VAN EECKHAUT (Vrije Universiteit Brussel)
• A. VAN SCHEPDAEL (KU Leuven)

Registration fees include full access to the DA-PBA Symposium, all symposium materials, coffee breaks and lunches during the symposium and access to the welcome reception on Sunday 11/09/22.

*Proof of student/PhD status will be checked upon arrival for registration.The document provided can be a copy of your student card including the mentioning of the academic year, a certificate of enrolment, or a letter signed by your supervisor

Online registration form

The fee does not include accommodation and so you have to organize your own accommodation

We advise you to book your hotel as soon as possible.

Rooms have been pre-booked with a reduced rate in some hotels:

UMONS – Campus Plaine de Nimy – Les Grands Amphis – Chemin du Champ de Mars 8, 7000 Mons

Google map

By car

Mons is situated between Paris and Brussels on the E19 motorway, exit 24.

By train

Mons station — The new station created by Santiago Calatrava is currently under construction.

Two trains connect Brussels to Mons every hour.

There is one direct train linking Brussels airport – Zaventem to Mons every hour. Attention: «Mons» is written in Dutch: «Bergen ».

You can take a TEC bus every 30 minutes between Brussels South Airport and the main Charleroi train station (Charleroi-Sud) where you can take a direct train to Mons.

The campus Plaine de Nimy is only a 15 minute-walk from the railway station.

By plane

Brussels South Airport, located in Charleroi, is 30 minutes from Mons by car : www.charleroi-airport.com

Brussels Airport, the country’s main international airport, is only 50 minutes from Mons : www.brusselsairport.be